Cardiol Therapeutics (TSX:CRDL, NASDAQ:CRDL) announced that CEO, David Elsley, will present a company overview at the Cantor Fitzgerald 2023 Global Healthcare Conference on September 26, 2023, at 4:55 p.m. ET. The presentation will focus on Cardiol's research and clinical development of therapies for heart disease, specifically anti-inflammatory and anti-fibrotic treatments. The presentation can be viewed via live video webcast at www.wsw.com/webcast/cantor19/crdl/2077845.
Advertisement Go to Proactive UK Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Advertisement Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Advertisement Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com